NCT04098003View on ClinicalTrials.gov

Investigation of the Gut Microbiome and Statin Response

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

February 6, 2020

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2026

Conditions
Healthy Volunteers
Interventions
DRUG

Rosuvastatin

rosuvastatin 20 mg daily or placebo for eight weeks

DRUG

Placebo

Matched placebo control

Trial Locations (1)

19104

University of Pennsylvania, Phildelphia

All Listed Sponsors
lead

Sony Tuteja

OTHER